John Levy
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- Virus-based gene therapy research
Papers in
- Genetics 13
- Virus-based gene therapy research 13
-
- CRISPR and Genetic Engineering 4
- Viral Infectious Diseases and Gene Expression in Insects 4
- RNA Interference and Gene Delivery 3
- Bacillus and Francisella bacterial research 1
- Co-authors
- Charles J. Link (7 shared papers)Sergei Zolotukhin (1 shared paper)G. Tim Bowden (1 shared paper)Joanne S. Finch (2 shared papers)Frederick E. Domann (1 shared paper)Donald W. Moorman (3 shared papers)Erlinda M. Gordon (4 shared papers)Gerardo Cornelio (3 shared papers)
- Journals
- International Journal of Oncology (3 papers)Methods in enzymology on CD-ROM/Methods in enzymology (3 papers)Human Gene Therapy (2 papers)Molecular Carcinogenesis (1 paper)Anesthesia & Analgesia (1 paper)
- Partner nations
- United StatesPhilippinesCzechia
In The Last Decade
John Levy
17 papers receiving 316 citations
Peers
Comparison fields: 5 of 69
- Biotechnology 74
- Genetics 154
- Biophysics 25
- Oncology 94
- Molecular Biology 209
Countries citing papers authored by John Levy
This map shows the geographic impact of John Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Levy more than expected).
Fields of papers citing papers by John Levy
This network shows the impact of papers produced by John Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Levy. The network helps show where John Levy may publish in the future.
Co-authors
The 25 scholars most cited alongside John Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 84 | |
| 2 | 1994 | 58 | |
| 3 | 2004 | 40 | |
| 4 | 1997 | 37 | |
| 5 | 1996 | 35 | |
| 6 | 2006 | 29 | |
| 7 | 1997 | 22 | |
| 8 | 2007 | 16 | |
| 9 | 1988 | 5 | |
| 10 | 1990 | 4 | |
| 11 | 1991 | 3 | |
| 12 | 1999 | 3 | |
| 13 | 1993 | 2 | |
| 14 | 2000 | 2 | |
| 15 | 1999 | 1 | |
| 16 | 1999 | 1 | |
| 17 | Murine retroviral vector producer cells survival and toxicity in the dog liver. | 2001 | 1 |
| 18 | 2004 | 0 |
About John Levy
John Levy is a scholar working on Genetics, Molecular Biology, Oncology, Biotechnology and Epidemiology, having authored 18 papers that have together received 343 indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Cancer Research and Treatments (5 papers), CRISPR and Genetic Engineering (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), RNA Interference and Gene Delivery (3 papers), CAR-T cell therapy research (3 papers), Herpesvirus Infections and Treatments (3 papers) and Bacillus and Francisella bacterial research (1 paper). The work is most often cited by research in Biotechnology (74 citations), Genetics (154 citations), Biophysics (25 citations), Oncology (94 citations) and Molecular Biology (209 citations). John Levy has collaborated with scholars based in United States, Philippines and Czechia. Frequent co-authors include Charles J. Link, Sergei Zolotukhin, G. Tim Bowden, Joanne S. Finch, Frederick E. Domann, Donald W. Moorman, Erlinda M. Gordon, Gerardo Cornelio, Frederick L. Hall and Steven R. Kain. Their work appears in journals such as International Journal of Oncology, Methods in enzymology on CD-ROM/Methods in enzymology, Human Gene Therapy, Molecular Carcinogenesis and Anesthesia & Analgesia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.